Skip to main content
Year archive

Prism Medico and Pharmacy Ltd. — 2021 filings

All 75 regulatory filings released by Prism Medico and Pharmacy Ltd. (512217) in 2021, sourced directly from the official regulator.

75 Filings
2021 Period
2021 filings (75)
Filing Released Lang
The Trading window for dealing in securities of the Company will be closed for the purpose of declaration of un-audited Financial Results of the Company for the quarter ending 31st December, ....
Regulatory Filings
2021-12-31 English
Attaching herewith the Notice of Extra Ordinary General Meeting to be held on Monday, 31st January 2022, through Video Conferencing/ Other Audio Visual Means.
Regulatory Filings
2021-12-31 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Thursday, 30thDecember 2021has appointed Mr. Davender ....
Regulatory Filings
2021-12-30 English
With reference to the above captioned subject, this to inform you that the Board of Directors of the Company at their meeting held on Thursday, 30th December2021 at 11.00 a.m.concluded ....
Regulatory Filings
2021-12-30 English
We wish to inform you that official website of the Company has changed from www.prismmedico.com to www.prismmedico.in
Regulatory Filings
2021-12-27 English
We wish to inform you that official website of the Company has changed from www.prismmedico.com to www.prismmedico.in
Regulatory Filings
2021-12-27 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/12/2021 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2021-12-22 English
With reference to the above mail, We regret to inform you that due to an inadvertent error cash flow statement in this regard was not attached. Further, we are attaching herewith Cash Flow ....
Regulatory Filings
2021-11-22 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, 13th November 2021 at 02.30 p.m concluded ....
Regulatory Filings
2021-11-13 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2021-11-03 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2021-10-04 English
We hereby submit a certificate duly signed by Purva Sharegistry (I) Pvt Ltd, Share Transfer Agent and the Compliance Officer of Prism Medico & Pharmacy Limited, for the half year ended ....
Regulatory Filings
2021-10-04 English
This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is ....
Regulatory Filings
2021-10-01 English
Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter and half year ended 30th September, ....
Regulatory Filings
2021-09-30 English
We hereby submit Scrutinizer's report of e-voting conducted for the 19th Annual General Meeting of the Company.
Regulatory Filings
2021-09-29 English
With reference to the above captioned subject, we hereby submit Scrutinizer's report and Voting results under Reg. 44 of SEBI (LODR) Regulations 2015 of e-voting conducted for the 19th ....
Regulatory Filings
2021-09-29 English
Pursuant to Regulation 30 (2) of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015, we hereby submit the proceedings of Annual General Meeting held on Monday, ....
Regulatory Filings
2021-09-27 English
please find enclosed copies of the newspaper advertisement of Notice of the 19th Annual General Meeting, Remote E-voting and Book Closure.
Regulatory Filings
2021-09-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-08-27 English
We hereby enclose a copy of the Annual Report of the Company for the financial year ended 31st March, 2021.
Regulatory Filings
2021-08-26 English
We hereby enclose copy of the revised Notice of the 19th Annual General Meeting of the Company for the financial year ended 31st March, 2021 to be held on Monday, 27th September 2021, through ....
Regulatory Filings
2021-08-25 English
We hereby enclose copy of the Notice of the 19th Annual General Meeting of the Company for the financial year ended 31st March, 2021 to be held on Monday, 27th September 2021, through Video ....
Regulatory Filings
2021-08-25 English
The Register of Member and Share Transfer Books of the Company will remain closed from Tuesday, September 21,2021 to Monday, September 27, 2021 (both days inclusive) for taking record ....
Regulatory Filings
2021-08-21 English
Prism Medico and Pharmacy Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2021 to September 27, 2021 (both ....
Regulatory Filings
2021-08-21 English
Board of Directors in their meeting held on Friday, 20th August 2021 hereby submit requite disclosure as per regulation 30 of Schedule III of SEBI (LODR) Regulations, 2015. Kindly take ....
Regulatory Filings
2021-08-20 English
we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 20th August 2021 at 10.00 a.m concluded at 12:00 noon. Following transactions were considered ....
Regulatory Filings
2021-08-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-08-19 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-08-12 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2021 ,inter alia, to consider and approve To consider and ....
Regulatory Filings
2021-08-12 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-08-10 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-08-07 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-08-05 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-07-27 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-07-24 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-07-22 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Monday, 19th July 2021 at 11.00 a.m concluded at ....
Regulatory Filings
2021-07-19 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2021 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2021-07-12 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 09th July 2021 at 10.00 a.m concluded at ....
Board/Management Information
2021-07-09 English
This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is ....
Regulatory Filings
2021-07-05 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2021-07-05 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-06-30 English
The Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter ended 30th June, 2021 for all ....
Regulatory Filings
2021-06-30 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajooni Biotech Ltd
Regulatory Filings
2021-06-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-06-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-06-25 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-06-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-06-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-06-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2021-06-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gursimran Singh
Regulatory Filings
2021-06-16 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gursimran Singh
Regulatory Filings
2021-06-15 English
We hereby submit a certificate duly signed by Purva Sharegistry (I) Pvt Ltd, Share Transfer Agent and the Compliance Officer of Prism Medico & Pharmacy Limited, for the half year ended ....
Regulatory Filings
2021-06-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-06-07 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-06-04 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-06-04 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-06-02 English
Enclosed find the Certificate in relation to non-applicability of Secretarial Compliance Report as per Reg 24A of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, ....
Regulatory Filings
2021-06-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punjab Biotechnology Park Ltd
Regulatory Filings
2021-05-26 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gursimran Singh
Regulatory Filings
2021-05-21 English
We are enclosing herewith: 1. Audited Financial Results for the quarter and year ended on 31st March, 2021. 2. Auditors Report on Audited Financial Results for the quarter and year ....
Regulatory Filings
2021-04-27 English
The Board of Directors of the Company at their meeting held on Tuesday, 27th April 2021 at 11.30 a.m concluded at 12.30 p.m. Following transactions were approved: 1. Audited Standalone ....
Regulatory Filings
2021-04-27 English
We hereby furnish a copy of Compliance Certificate issued by M.R. Chechi & Associates, Practicing Company Secretaries, Chandigarh.
Regulatory Filings
2021-04-22 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2021 ,inter alia, to consider and approve To consider and ....
Regulatory Filings
2021-04-19 English
Website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is www.prismmedico.com
Regulatory Filings
2021-04-05 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2021-04-05 English
Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter and year ended 31st March, 2021 ....
Regulatory Filings
2021-03-31 English
Pursuant to the provision of Regulation 32 of SEBI (Listed obligation and disclosure Requirements) Regulation, 2015 read with Circular No. CIR/CFD/CMD1/162/2019 dated 24-12-2019 issued ....
Regulatory Filings
2021-02-18 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 12th February 2021 appointed Mrs. Simmi ....
Regulatory Filings
2021-02-12 English
Pursuant to the Regulation 33 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform that the Board of Directors of the Company at their meeting ....
Regulatory Filings
2021-02-12 English
we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 12th February 2021 at 03.00 p.m concluded at 03.30 p.m. Following transactions were approved: ....
Regulatory Filings
2021-02-12 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve In continuation ....
Regulatory Filings
2021-02-04 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2021-02-04 English
This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is ....
Regulatory Filings
2021-01-27 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2021-01-06 English
The Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter ended 31st December, 2020 for ....
Regulatory Filings
2021-01-04 English